(RTTNews) - Sanofi (SNYNF, SNY) announced Wednesday that the US Food and Drug Administration has granted fast track designation to the company's mRNA vaccine candidate for the prevention of chlamydia ...

It’s almost Valentine’s Day, and nothing says romance like a column about a sexually transmitted infection! The next time you take your adolescent in for a checkup, you may find that your health care ...

To reduce the spread of sexually transmitted diseases, the U.S. Centers for Disease Control and Prevention has proposed recommending a common antibiotic be taken after having unprotected sex. Under ...

San Francisco recorded a significant decline in sexually transmitted infections in 2025, with cases of syphilis, chlamydia ...

A Chlamydia vaccine showed promising results in an early-stage clinical trial conducted by researchers in the U.K. and Denmark. The early phase of the research found the experimental vaccine to be ...

City data show syphilis fell 24%, chlamydia dropped 18% and gonorrhea declined 5% year over year, according to reporting by ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA) has ...

A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI). There is currently no ...

Chlamydia and gonorrhea are on the rise in New York City, a new report reveals. According to the 2023 Sexually Transmitted Infections (STI) Surveillance Report recently released by the New York City ...